文献速递心血管胸部CT

心外膜脂肪衰减而非体积可预测非典型胸痛患者阻塞性冠心病及高危斑块特征

Epicardial fat attenuation, not volume, predicts obstructive coronary artery disease and high risk plaque features in patients with atypical chest pain.
PubMed 文献 · Br J Radiol · 2020-08-26

本研究纳入255例因非典型胸痛疑诊冠心病行冠状动脉CTA的患者,在非对比图像上量化心外膜脂肪体积与衰减。结果显示心外膜脂肪衰减(而非体积)是阻塞性冠心病和高危斑块特征的独立预测因子,将其加入传统危险因素和钙化积分可提高预测AUC但未达统计学显著。

要点

  • 心外膜脂肪衰减较低与阻塞性冠心病和高危斑块特征相关,且为独立预测因子。
  • 心外膜脂肪体积在多变量分析中与阻塞性冠心病及高危斑块特征均无显著关联。
  • 将心外膜脂肪衰减加入传统危险因素和钙化积分后,预测AUC提高但未达统计学显著。

核心结论

  • 心外膜脂肪衰减而非体积是阻塞性冠心病和高危斑块特征的独立预测因子。
  • 将心外膜脂肪衰减加入传统心血管危险因素和钙化积分可改善阻塞性冠心病和高危斑块特征的验前概率估计。

研究设计与样本

  • 研究纳入因非典型胸痛临床疑诊冠心病而转诊行冠状动脉CTA的患者。
  • 共255例患者,中位年龄51岁(四分位距41-60岁),男性占51.8%。
  • 在非对比图像上量化钙化积分、心外膜脂肪体积和心外膜脂肪衰减,并评估CTA上阻塞性冠心病和高危斑块特征。

诊断标准与关键数值

  • 阻塞性冠心病定义为CTA上狭窄≥50%。
  • 有阻塞性冠心病患者的心外膜脂肪衰减为-86 HU(IQR -88至-82 HU),低于无阻塞性冠心病患者的-84 HU(IQR -87至-82 HU),p=0.0486。
  • 有高危斑块特征患者的心外膜脂肪衰减为-86 HU(IQR -88至-83 HU),低于无高危斑块特征患者的-83 HU(IQR -86至-81.750 HU),p<0.0001。
  • 心外膜脂肪衰减与阻塞性冠心病的未校正OR为0.90(95%CI 0.81-0.99),p=0.0248;与高危斑块特征的未校正OR为0.83(95%CI 0.76-0.90),p<0.0001,多变量分析中均保持显著。
  • 将心外膜脂肪衰减加入传统危险因素和钙化积分后,预测阻塞性冠心病的AUC为0.76(95%CI 0.70-0.81)对比0.71(95%CI 0.65-0.77),预测高危斑块特征的AUC为0.92(95%CI 0.88-0.95)对比0.89(95%CI 0.85-0.93),均未达统计学显著。

临床应用与阅片要点

  • 心外膜脂肪衰减可作为反映脂肪「质量」的指标,较单纯体积测量可能更有助于评估阻塞性冠心病和高危斑块特征风险。
  • 作者认为心外膜脂肪衰减是优于心外膜脂肪体积的阻塞性冠心病和高危斑块特征预测因子,并可能解释单纯心外膜脂肪体积增加与冠心病关联不一致的现象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study sought to investigate the association between volume and attenuation of epicardial fat and presence of obstructive coronary artery disease (CAD) and high-risk plaque features (HRPF) on CT angiography (CTA) in patients with atypical chest pain and whether the association, if any, is independent of conventional cardiovascular risk factors and coronary artery calcium score (CACS).

METHODS: Patients referred for coronary CTA with atypical chest pain and clinical suspicion of CAD were included in the study. Quantification of CACS, epicardial fat volume (EFV) and epicardial fat attenuation (EFat) was performed on non-contrast images. CTA was evaluated for presence of obstructive CAD and presence of HRPF.

RESULTS: 255 patients (median age [interquartile range; IQR]: 51[41-60] years, 51.8% males) were included. On CTA, CAD, obstructive CAD (≥50% stenosis) and CTA-derived HRPFs was present in 133 (52.2%), 37 (14.5%) and 82 (32.2%) patients respectively. A significantly lower EFat was seen in patients with obstructive CAD than in those without (-86HU [IQR:-88 to -82 HU] vs -84 [IQR:-87 HU to -82 HU]; p = 0.0486) and in patients with HRPF compared to those without (-86 HU [IQR:-88 to -83 HU] vs -83 HU [-86 HU to -81.750 HU]; p < 0.0001). EFat showed significant association with obstructive CAD (unadjusted Odd's ratio (OR) [95% CI]: 0.90 [0.81-0.99];p = 0.0248) and HRPF (unadjusted OR [95% CI]: 0.83 [0.76-0.90];p < 0.0001) in univariate analysis, which remained significant in multivariate analysis. However, EFV did not show any significant association with neither obstructive CAD nor HRPF in multivariate analysis. Adding EFat to conventional coronary risk factors and CACS in the pre-test probability models increased the area-under curve (AUC) for prediction of both obstructive CAD (AUC[95% CI]: 0.76 [0.70-0.81] vs 0.71 [0.65-0.77)) and HRPF (AUC [95% CI]: 0.92 [0.88-0.95] vs 0.89 [0.85-0.93]), although not reaching statistical significance.

CONCLUSION: EFat, but not EFV, is an independent predictor of obstructive CAD and HRPF. Addition of EFat to traditional cardiovascular risk factors and CACS improves estimation for pretest probability of obstructive CAD and HRPF.

ADVANCES IN KNOWLEDGE: EFat is an important attribute of epicardial fat as it reflects the "quality" of fat, taking into account the effects of brown-white fat transformation and fibrosis, as opposed to mere evaluation of "quantity" of fat by EFV. Our study shows that EFat is a better predictor of obstructive CAD and HRPF than EFV and can thus explain the inconsistent association of increased EFV alone with CAD.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Pandey NN, Sharma S, Jagia P, et al. Epicardial fat attenuation, not volume, predicts obstructive coronary artery disease and high risk plaque features in patients with atypical chest pain. Br J Radiol. 2020. PMID: 32706985. doi:10.1259/bjr.20200540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。